DRUG · Mapped RxNorm record
Carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
NCT01366144
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Laboratory Biomarker Analysis
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Pharmacological Study
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Veliparib
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedVeliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Carcinomaverified · MONDO: breast carcinoma
Carcinoma of Unknown Primaryunresolved
Liver Failureverified · MONDO: liver failure
Lung Carcinomaverified · MONDO: lung carcinoma
Melanomaverified · MONDO: melanoma
Metastatic Malignant Solid Neoplasmunresolved
Ovarian Carcinomaverified · MONDO: ovarian carcinoma
Renal Failureverified · MONDO: kidney failure
Unresectable Malignant Neoplasmunresolved
Interventions
CarboplatinDRUG · verified · RxNorm: carboplatin
PaclitaxelDRUG · verified · RxNorm: paclitaxel
VeliparibDRUG
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Abbottcollaborator
Mapped research locations
The BronxNew York, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1TampaFlorida, United States1DetroitMichigan, United States1SacramentoCalifornia, United States1MadisonWisconsin, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01366144 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.